Annual Report | Duopharma Biotech Berhad

Annual Reports

Annual Reports : 2019

	1. Duopharma Biotech Berhad 2. Vision & Mission, Tagline and Core value 3. Section 1: About Us 4. Section 2: Strategic Report 5. Section 3: Governance 6. Section 4: Financial Report 7. Section 5: Other Information
Click here for full version

Annual Reports : 2018

	1. Core value, Vision & Mission, and Tagline 2. Section 1: About Us 3. Section 2: Strategic Report 4. Section 3: Governance 5. Financial Report 6. Shareholder’s Information 7. Proxy Form
Click here for full version

Annual Reports : 31 December 2017

	1. Vision & Mision 2. Core Values 3. Financial Calender 4. Financial Highlight 5. Chairman's Statement 6. Group Managing Director's Management Discussion and Analysis 7. Sustainability & Corporate Responsibility 8. Calendar of Major Events 9. Corporate Information 10. Board Structure 11. Corporate Structure 12. Board of Directors 13. Senior Management 14. Corporate Governance 15. Report of the Audit and Integrity Committee 16. Report of the Risk Management Committee 17. Report of the Nomination and Remuneration Committee 18. Statement on Risk Management and Internal Control 19. Other Disclosures 20. Statements of Financial Position 21. Statements of Profit or Loss and other Comprehensive Income 22. Consolidated Statement of Changes in Equity 23. Statement of Changes in Equity 24. Statements of Cash Flows 25. Notes to the Financial Statements 26. Analysis of Shareholdings 27. List of Properties 28. Recurrent Related Party Transactions of a Revenue or Trading Nature 29. Notice of Annual General Meeting 30. Statement Accompanying the Notice of the Twelve Annual General Meeting of CCM Duopharma Biotech Berhad 31. Proxy Form
Click here for full version

Annual Reports : 31 December 2016

	1. Vision & Mision 2. Core Values 3. Financial Calender 4. Financial Highlight 5. Chief Executive Officer's Management Discussion and Analysis 6. Sustainability & Corporate Responsibility 7. Calendar of Major Events 8. Corporate Information 9. Board Structure 10. Corporate Structure 11. Board of Directors 12. Senior Management 13. Statement on Corporate Governance 14. Report of the Audit and Risk Management Committee 15. Report of the Nomination and Remuneration Committee 16. Statement on Risk Management and Internal Control 17. Other Disclosures 18. Directors' Report 19. Statements of Financial Position 20. Statements of Profit or Loss and other Comprehensive Income 21. Consolidated Statement of Changes in Equity 22. Statement of Changes in Equity 23. Statements of Cash Flows 24. Notes to the Financial Statements 25. Statement by Directors 26. Statutory Declaration 27. Independent Auditor's Report 28. Analysis of Shareholdings 29. List of Properties 30. Recurrent Related Party Transactions of a Revenue or Trading Nature 31. Notice of Annual General Meeting 32. Statement Accompanying the Notice of the Twelve Annual General Meeting of CCM Duopharma Biotech Berhad 33. Proxy Form
Click here for full version

Annual Reports : 31 December 2015

	1. Financial Calender 2. Financial Highlight 3. Chairman's Statement 4. Chief Executive Officer's Operations Review 5. Corporate Information 6. Board Structure 7. Corporate Structure 8. Board of Directors 9. Senior Management 10. Statement on Corporate Governance 11. Report of the Audit and Risk Management Committee 12. Report of the Nomination and Remuneration Committee 13. Statement on Risk Management and Internal Control 14. Directors' Report 15. Statements of Financial Position 16. Statements of Profit or Loss and other Comprehensive Income 17. Consolidated Statement of Changes in Equity 18. Statement of Changes in Equity 19. Statements of Cash Flows 20. Notes to the Financial Statements 21. Analysis of Shareholdings 22. List of Properties 23. Recurrent Related Party Transactions of a Revenue or Trading Nature 24. Notice of Annual General Meeting 25. Statement Accompanying the Notice of the Twelve Annual General Meeting of CCM Duopharma Biotech Berhad 26. Proxy Form
Click here for full version

Annual Reports : 31 December 2014

	1. Financial Calender 2. Financial Highlight 3. Chairman's Statement 4. Chief Executive Officer's Operations Review 5. Corporate Information 6. Board Structure 7. Corporate Structure 8. Board of Directors 9. Senior Management 10. Statement on Corporate Governance 11. Report of the Audit and Risk Management Committee 12. Report of the Nomination and Remuneration Committee 13. Statement on Risk Management and Internal Control 14. Directors' Report 15. Statements of Financial Position 16. Statements of Profit or Loss and other Comprehensive Income 17. Consolidated Statement of Changes in Equity 18. Statement of Changes in Equity 19. Statements of Cash Flows 20. Notes to the Financial Statements 21. Analysis of Shareholdings 22. List of Properties 23. Recurrent Related Party Transactions of a Revenue or Trading Nature 24. Notice of Annual General Meeting 25. Statement Accompanying the Notice of the Twelve Annual General Meeting of CCM Duopharma Biotech Berhad 26. Proxy Form
Click here for full version

Annual Reports : 31 December 2013

	1. Financial Calender 2. Financial Highlight 3. Chairman's Statement 4. Chief Executive Officer's Operations Review 5. Corporate Information 6. Board Structure 7. Corporate Structure 8. Board of Directors 9. Senior Management 10. Statement on Corporate Governance 11. Report of the Audit and Risk Management Committee 12. Report of the Nomination and Remuneration Committee 13. Statement on Risk Management and Internal Control 14. Directors' Report 15. Statements of Financial Position 16. Statements of Profit or Loss and other Comprehensive Income 17. Consolidated Statement of Changes in Equity 18. Statement of Changes in Equity 19. Statements of Cash Flows 20. Notes to the Financial Statements 21. Analysis of Shareholdings 22. List of Properties 23. Recurrent Related Party Transactions of a Revenue or Trading Nature 24. Notice of Annual General Meeting 25. Statement Accompanying the Notice of the Twelve Annual General Meeting of CCM Duopharma Biotech Berhad 26. Proxy Form
Click here for full version

Annual Reports : 31 December 2012

	1. Financial Calender 2. Financial Highlight 3. Chairman's Statement 4. Chief Executive Officer's Operations Review 5. Corporate Information, Corporate Structure 6. Board Structure 7. Corporate Structure 8. Board of Directors 9. Senior Management 10. Statement on Corporate Governance 11. Report of the Audit and Risk Management Committee 12. Report of the Nomination and Remuneration Committee 13. Statement on Risk Management and Internal Control 14. Directors' Report 15. Statements of Financial Position 16. Statements of Profit or Loss and other Comprehensive Income 17. Consolidated Statement of Changes in Equity 18. Statement of Changes in Equity 19. Statements of Cash Flows 20. Notes to the Financial Statements 21. Statement by Directors 22. Statutory Declaration 23. Independent Auditors' Report 24. Analysis of Shareholdings 25. List of Properties 26. Recurrent Related Party Transactions of a Revenue or Trading Nature 27. Notice of Annual General Meeting 28. Statement Accompanying the Notice of the Twelve Annual General Meeting of CCM Duopharma Biotech Berhad 29. Proxy Form
Click here for full version

Annual Reports : 31 December 2011

	1. Financial Calender 2. Chairman's Statement 3. Chief Executive Officer's Review 4. Corporate Information, Board Structure 5. Board of Directors, Senior Management 6. Statement on Corporate Governance, Report of the Audit Committee, Report of the Nomination & Remuneration Committee, Report on Risk Management 7. Statement on Internal Control 8. Financial Statements 9. Notice of Annual General Meeting, Statement Accompanying Notice 10. Proxy Form
Click here for full version

Annual Reports : 31 December 2010

	1. Financial Calender 2. Chairman's Statement 3. Chief Executive Officer's Review 4. Corporate Information, Board Structure 5. Board of Directors, Senior Management 6. Statement on Corporate Governance, Report of the Audit Committee, Report of the Nomination & Remuneration Committee, Report on Risk Management 7. Statement on Internal Control 8. Financial Statements 9. Notice of Annual General Meeting, Statement Accompanying Notice 10. Proxy Form
Click here for full version

Annual Reports : 31 December 2009

	1. Financial Calender 2. Chairman's Statement 3. Chief Executive Officer's Review 4. Corporate Information, Board Structure 5. Board of Directors, Senior Management 6. Statement on Corporate Governance, Report of the Audit Committee, Report of the Nomination & Remuneration Committee, Report on Risk Management 7. Statement on Internal Control 8. Financial Statements 9. Notice of Annual General Meeting, Statement Accompanying Notice 10. Proxy Form
Click here for full version

Annual Reports : 31 December 2008

	1. Chairman's Statement 2. Chief Executive Officer's Review 3. Corporate Information, Board Structure 4. Board of Directors, Senior Management 5. Statement on Corporate Governance, Report of the Audit Committee, Report of the Nomination & Remuneration Committee, Report on Risk Management 6. Statement on Internal Control 7. Financial Statements 8. Notice of Annual General Meeting, Statement Accompanying Notice 9. Proxy Form
Click here for full version